Should we stop using tricyclic antidepressants in pregnancy?

被引:10
|
作者
Pariante, C. M. [1 ,2 ,3 ]
Seneviratne, G.
Howard, L. [2 ,3 ,4 ]
机构
[1] Kings Coll London, Sect Perinatal Psychiat, Dept Psychol Med, Inst Psychiat,James Black Ctr, London SE5 9NU, England
[2] Inst Psychiat, Biomed Res Ctr Mental Hlth, Natl Inst Hlth Res, London, England
[3] S London & Maudsley NHS Fdn Trust, London, England
[4] Kings Coll London, Sect Womens Mental Hlth, Hlth Serv & Populat Res Dept, Inst Psychiat, London SE5 9NU, England
基金
英国医学研究理事会;
关键词
ASSOCIATION; GUIDELINES; MANAGEMENT;
D O I
10.1017/S003329171000022X
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
A new Swedish study by Reis & Kallen describes approximately 15 000 women (and their babies) that, between 1995 and 2007, reported the use of antidepressants, or were prescribed such drugs, during pregnancy. In this study, pregnancy and teratogenic outcomes after exposure to tricyclic antidepressants are, for most measures, equal or worse than after exposure to selective serotonin reuptake inhibitors or other antidepressants. Based on this and on a review of the few other studies available (admittedly, a relatively small number of women on which conclusions can be based), the authors of this Editorial challenge the 'perinatal myth' that tricyclics are the safest choice in pregnancy.
引用
收藏
页码:15 / 17
页数:3
相关论文
共 50 条